December 14, 2021
Life Sciences
  • A two-shot course of the Pfizer-BioNTech COVID-19 vaccination may offer 70 percent protection against being hospitalized with the omicron variant. According to Discovery Ltd., South Africa’s largest medical-insurance provider, the protection is maintained across age groups and in the face of a range of chronic illnesses. The provider also said that the Pfizer vaccine is 33 percent effective against infection by the omicron variant. (Articles here and here)